Gainers
- Cognition Therapeutics CGTX shares rose 148.4% to $1.13 during Wednesday's pre-market session. The market value of their outstanding shares is at $46.9 million.
- Polyrizon PLRZ shares increased by 140.95% to $2.53. The company's market cap stands at $10.6 million.
- TC BioPharm (Holdings) TCBP stock increased by 68.18% to $0.79. The company's market cap stands at $6.4 million.
- CERo Therapeutics Hldgs CERO shares rose 44.02% to $0.09. The company's market cap stands at $13.2 million.
- Tonix Pharmaceuticals TNXP shares increased by 22.79% to $0.41. The company's market cap stands at $76.6 million.
- Evaxion Biotech EVAX shares rose 18.09% to $1.13. The company's market cap stands at $6.6 million.
Losers
- Petros Pharma PTPI shares decreased by 34.8% to $0.33 during Wednesday's pre-market session. The company's market cap stands at $3.2 million.
- TransCode Therapeutics RNAZ stock fell 33.5% to $4.2. The market value of their outstanding shares is at $2.9 million.
- Corvus Pharma CRVS stock fell 31.53% to $5.06. The market value of their outstanding shares is at $325.1 million.
- NewGenIvf Group NIVF shares declined by 23.32% to $0.32. The market value of their outstanding shares is at $4.4 million.
- Radiopharm Theranostics RADX shares fell 21.66% to $3.51. The company's market cap stands at $7.6 billion.
- SI-BONE SIBN stock fell 20.53% to $11.0. The company's market cap stands at $461.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CGTXCognition Therapeutics Inc
$1.15152.8%
CRVSCorvus Pharmaceuticals Inc
$4.48-39.4%
EVAXEvaxion Biotech AS
$1.1316.4%
NIVFNewGenIvf Group Ltd
$0.3270-22.8%
PLRZPolyrizon Ltd
$2.49137.1%
PTPIPetros Pharmaceuticals Inc
$0.3278-34.4%
RADXRadiopharm Theranostics Ltd
$4.500.45%
RNAZTransCode Therapeutics Inc
$3.85-39.0%
SIBNSI-BONE Inc
$13.55-2.10%
TCBPTC BioPharm (Holdings) PLC
$0.650338.7%
TNXPTonix Pharmaceuticals Holding Corp
$0.410222.9%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in